Vimta Labs Ltd
VIMTALABSVimta Labs Ltd
VIMTALABS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 22.45 | 3.30 | 0.48% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.58 | 5.12 | 0.70% |
Forecast & Ratings
Detailed Forecastfrom 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Vimta Labs Limited is engaged in providing testing and contract research services in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.
Investor Presentation
View olderPeers
Compare with peersDivi's Laboratories Ltd
Syngene International Ltd
Aarti Pharmalabs Ltd
Dishman Carbogen Amcis Ltd
Brooks Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 117.57 | 139.06 | 154.79 | 184.65 | 214.57 | 183.73 | 211.51 | 279.73 | 321.63 | 320.52 | ||||||||||
Raw Materials | 38.84 | 27.36 | 30.39 | 29.53 | 35.64 | 32.41 | 35.25 | 54.81 | 44.13 | 229.94 | ||||||||||
| Power & Fuel Cost | 0.00 | 8.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 28.80 | 33.05 | 43.15 | 49.10 | 55.19 | 57.63 | 57.80 | 71.42 | 86.32 | |||||||||||
| Selling & Administrative Expenses | 23.96 | 30.77 | 21.07 | 23.22 | 24.29 | 26.50 | 21.73 | 28.56 | 43.08 | |||||||||||
| Operating & Other expenses | 7.51 | 19.67 | 31.92 | 36.34 | 39.98 | 34.22 | 42.94 | 44.43 | 49.75 | |||||||||||
EBITDA | 18.46 | 19.90 | 28.26 | 46.46 | 59.47 | 32.97 | 53.79 | 80.51 | 98.35 | 90.58 | ||||||||||
| Depreciation/Amortization | 11.10 | 10.26 | 9.63 | 15.70 | 19.72 | 20.93 | 23.08 | 23.33 | 30.71 | 33.31 | ||||||||||
| PBIT | 7.36 | 9.64 | 18.63 | 30.76 | 39.75 | 12.04 | 30.71 | 57.18 | 67.64 | 57.27 | ||||||||||
| Interest & Other Items | 0.72 | 1.30 | 2.09 | 5.20 | 4.61 | 3.77 | 2.17 | 1.50 | 2.65 | 1.96 | ||||||||||
| PBT | 6.64 | 8.34 | 16.54 | 25.56 | 35.14 | 8.27 | 28.54 | 55.68 | 64.99 | 55.31 | ||||||||||
| Taxes & Other Items | 1.58 | 1.92 | 5.94 | 9.13 | 9.83 | 1.42 | 7.14 | 14.36 | 16.83 | 13.87 | ||||||||||
| Net Income | 5.06 | 6.42 | 10.60 | 16.43 | 25.31 | 6.85 | 21.40 | 41.32 | 48.16 | 41.44 | ||||||||||
| EPS | 2.29 | 2.90 | 4.79 | 7.43 | 11.45 | 3.10 | 9.68 | 18.69 | 21.77 | 18.73 | ||||||||||
| DPS | 1.00 | 1.00 | 0.00 | 2.00 | 2.00 | 0.00 | 2.00 | 2.00 | 2.00 | 2.00 | ||||||||||
| Payout ratio | 0.44 | 0.34 | 0.00 | 0.27 | 0.17 | 0.00 | 0.21 | 0.11 | 0.09 | 0.11 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vimta Labs Ltd | 19.32 | 3.30 | 0.48% |
| Divi's Laboratories Ltd | 55.30 | 7.90 | 0.79% |
| Syngene International Ltd | 64.21 | 8.24 | 0.17% |
| Aarti Pharmalabs Ltd | 21.98 | 2.73 | — |
Price Comparison
Compare VIMTALABS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Vimta Labs Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.6293% | Percentage of the fund’s portfolio invested in the stock 0.16% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/127 (-14) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJun 21, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Jun 21, 2023
Cash Dividend
Ex DateEx DateJun 16, 2022
Dividend/Share
₹2.00
Ex DateEx Date
Jun 16, 2022
Cash Dividend
Ex DateEx DateJun 25, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Jun 25, 2021
Cash Dividend
Ex DateEx DateJul 18, 2019
Dividend/Share
₹2.00
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateAug 14, 2018
Dividend/Share
₹2.00
Ex DateEx Date
Aug 14, 2018
News & Opinions
Vimta Labs Consolidated March 2023 Net Sales at Rs 81.82 crore, up 10.44% Y-o-Y
7 months ago•Moneycontrol
Stocks to watch on May 3, 2023
7 months ago•The Hindu Businessline
Heranba Industries Ltd leads losers in ‘B’ group
10 months ago•Business Standard
Vimta Labs Consolidated December 2022 Net Sales at Rs 77.38 crore, up 14.92% Y-o-Y
10 months ago•Moneycontrol
Vimta Labs consolidated net profit rises 35.63% in the September 2022 quarter
1 year ago•Business Standard
VIMTA Labs forays into electrical, electronics testing
1 year ago•The Hindu Businessline
Vimta Labs allots 9963 equity shares under ESOP
1 year ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 11.74%, vs industry avg of 8.01%
Increasing Market Share
Over the last 5 years, market share increased from 1.74% to 1.83%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 24%, vs industry avg of 15.02%